Skip to search.
 TSX Down0.80% TSX Ventures 0.00%

Acorda Therapeutics, Inc. (ACOR)

-NMS

34.84 Jun 19, 4:00PM EDT

Add to Portfolio
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period Ending2012-12-302011-12-302010-12-30
Net Income 154,958   30,605   (11,769)
Operating Activities, Cash Flows Provided By or Used In
Depreciation9,112  11,479  8,520  
Adjustments To Net Income(111,661)32,980  17,531  
Changes In Accounts Receivables(3,499)(556)(16,533)
Changes In Liabilities1,339  (15,180)15,870  
Changes In Inventories7,427  10,036  (31,526)
Changes In Other Operating Activities(5,557)(3,028)(1,308)
Total Cash Flow From Operating Activities 52,119   66,336   (19,215)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(10,384)(2,192)(2,446)
Investments(57,705)(39,236)14,795  
Other Cash flows from Investing Activities(3,194)(3,595)(6,998)
Total Cash Flows From Investing Activities (71,283) (45,023) 5,351  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock4,339  3,962  8,041  
Net Borrowings(1,253)(1,962)(6,850)
Other Cash Flows from Financing Activities -   -   -  
Total Cash Flows From Financing Activities 3,086   2,000   1,191  
Effect Of Exchange Rate Changes -   -   -  
Change In Cash and Cash Equivalents (16,078) 23,313   (12,673)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.